Economic modelling of different treatment strategies for haemophilia A with high‐responding inhibitors
- 26 June 2003
- journal article
- review article
- Published by Wiley in Haemophilia
- Vol. 9 (4) , 521-540
- https://doi.org/10.1046/j.1365-2516.2003.00783.x
Abstract
Summary. This paper reports a systematic review of the cost‐effectiveness of treatment options in patients with haemophilia A with inhibitors. As very little relevant published evidence was identifi...Keywords
This publication has 25 references indexed in Scilit:
- Assessing health-related quality-of-life in patients with severe haemophilia A and BPsychology, Health & Medicine, 1999
- Analysis of the North American Immune Tolerance Registry (NAITR) 1993–1997: Current Practice ImplicationsVox Sanguinis, 1999
- Haemophilia prophylaxis in young patients–a long‐term follow‐upJournal of Internal Medicine, 1997
- Episodic versus prophylactic infusions for hemophilia A: A cost-effectiveness analysisThe Journal of Pediatrics, 1996
- Recommendations for the treatment of factor VIII inhibitorsBlood Coagulation & Fibrinolysis, 1996
- Cross sectional stature and weight reference curves for the UK, 1990.Archives of Disease in Childhood, 1995
- A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacsJournal of Internal Medicine, 1994
- The Management of Hemophilia Patients With InhibitorsTransfusion Medicine Reviews, 1992
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Efficacy and safety of vapor‐heated anti‐inhibitor coagulant complex in hemophilia patients. FEIBA Study GroupTransfusion, 1990